We are live on ! Find out more
HS

HighVista Strategies Portfolio holdings

AUM $362M
1-Year Est. Return 230.96%
This Fund
S&P 500
This Quarter Est. Return
+12.21%
1 Year Est. Return
+230.96%
3 Year Est. Return
+518.4%
5 Year Est. Return
+644.94%
10 Year Est. Return
+2,223.31%
AUM
$290M
AUM Growth
+$16.2M
Cap. Flow
-$4.34M
Cap. Flow %
-1.5%
Top 10 Hldgs %
25.51%
Holding
174
New
37
Increased
46
Reduced
48
Closed
32

Top Buys

Rank Stock Value
1
AMGN icon
Amgen
AMGN
+$3.3M
2
GEV icon
GE Vernova
GEV
+$2.82M
3
PTGX icon
Protagonist Therapeutics
PTGX
+$2.76M
4
DYN icon
Dyne Therapeutics
DYN
+$2.61M
5
AMZN icon
Amazon
AMZN
+$2.59M

Top Sells

Rank Stock Value
1
INSM icon
Insmed
INSM
+$6M
2
ETRN
Equitrans Midstream Corporation Common Stock
ETRN
+$4.02M
3
CERE
Cerevel Therapeutics Holdings, Inc. Common Stock
CERE
+$3.97M
4
MRUS
Merus
MRUS
+$2.23M
5
META icon
Meta Platforms (Facebook)
META
+$2.06M

Sector Composition

Rank Sector Weight
1 Healthcare 46.45%
2 Technology 15.69%
3 Consumer Discretionary 9.1%
4 Industrials 4.98%
5 Financials 4.34%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
EQR icon
151
Equity Residential
EQR
$24.6B
– –
-25,900
Closed -$1.8M
FDMT icon
152
4D Molecular Therapeutics
FDMT
$599M
– –
-15,532
Closed -$326K
FSV icon
153
FirstService
FSV
$6.32B
– –
-8,700
Closed -$1.33M
HTHT icon
154
Huazhu Hotels Group
HTHT
$12.8B
– –
-19,029
Closed -$634K
HUBS icon
155
HubSpot
HUBS
$11B
– –
-2,100
Closed -$1.24M
IDYA icon
156
IDEAYA Biosciences
IDYA
$3.57B
– –
-40,856
Closed -$1.43M
JBHT icon
157
JB Hunt Transport Services
JBHT
$25B
– –
-8,000
Closed -$1.28M
META icon
158
Meta Platforms (Facebook)
META
$1.53T
– –
-4,090
Closed -$2.06M
MU icon
159
Micron Technology
MU
$975B
– –
-8,900
Closed -$1.17M
NVDA icon
160
NVIDIA
NVDA
$5.28T
– –
-12,000
Closed -$1.48M
PFE icon
161
Pfizer
PFE
$152B
– –
-60,300
Closed -$1.69M
RBC icon
162
RBC Bearings
RBC
$17.4B
– –
-4,400
Closed -$1.19M
RIG icon
163
Transocean
RIG
$6.54B
– –
-229,725
Closed -$1.23M
ROP icon
164
Roper Technologies
ROP
$39.5B
– –
-2,400
Closed -$1.35M
SRPT icon
165
Sarepta Therapeutics
SRPT
$1.88B
– –
-2,364
Closed -$374K
STZ icon
166
Constellation Brands
STZ
$22.8B
– –
-4,600
Closed -$1.18M
TAL icon
167
TAL Education Group
TAL
$6.77B
– –
-29,900
Closed -$319K
TOST icon
168
Toast
TOST
$20.2B
– –
-48,300
Closed -$1.24M
TRML
169
DELISTED
Tourmaline Bio
TRML
– –
-83,397
Closed -$1.07M
UTHR icon
170
United Therapeutics
UTHR
$22.2B
– –
-1,409
Closed -$449K
WCC
171
WESCO International
WCC
$18B
– –
-9,797
Closed -$1.55M
WMT icon
172
Walmart Inc
WMT
$898B
– –
-22,500
Closed -$1.52M
CERE
173
DELISTED
Cerevel Therapeutics Holdings, Inc. Common Stock
CERE
– –
-97,200
Closed -$3.97M
ETRN
174
DELISTED
Equitrans Midstream Corporation Common Stock
ETRN
– –
-310,000
Closed -$4.02M
3 4 5 6
7

Similar funds

SIAG
Safeguard Investment Advisory Group Corona, California $362M AUM 20.96% 1-Year Est. Return
MS
Millington Securities Red Bank, New Jersey $362M AUM
WTFG
Wood Tarver Financial Group Boise, Idaho $362M AUM 14.75% 1-Year Est. Return
A6
Anchor @ 65 Singapore $362M AUM 20.02% 1-Year Est. Return
PI
Pennant Investors Summit, New Jersey $361M AUM 134.26% 1-Year Est. Return
ACM
Anfield Capital Management Irvine, California $363M AUM 24.08% 1-Year Est. Return
PPG
Peak Planning Group Centennial, Colorado $361M AUM 22.01% 1-Year Est. Return
PWC
PYA Waltman Capital Knoxville, Tennessee $361M AUM 9.49% 1-Year Est. Return

HighVista Strategies's Q3 2024 Portfolio in Review

As of Q3 2024, HighVista Strategies held 174 positions worth $290M, up 5.9% from $274M the previous quarter. Its ten largest holdings account for 26% of the portfolio.

HighVista Strategies's Q3 2024 filing shows 37 new, 46 increased, 48 reduced and 32 closed positions. Its largest new stake was Amgen: 10,101 shares worth $3.25M. The largest sale was Insmed, an estimated $6M.

By sector, the portfolio is most concentrated in Healthcare at 46% of assets, up from 44% a quarter earlier, followed by Technology and Consumer Discretionary.

  • HighVista Strategies's largest Q3 2024 buy was Amgen: 10,101 shares worth $3.25M.
  • HighVista Strategies added most to Protagonist Therapeutics in Q3 2024, an estimated $2.76M increase.
  • HighVista Strategies's biggest Q3 2024 reduction was Insmed, cutting an estimated $6M.
  • HighVista Strategies fully exited Equitrans Midstream Corporation Common Stock in Q3 2024, selling an estimated $4.02M.
  • HighVista Strategies's ten largest holdings make up 26% of its $290M portfolio in Q3 2024.
  • HighVista Strategies opened 37 new positions and closed 32 in Q3 2024.
  • HighVista Strategies's portfolio value rose 5.9% quarter-over-quarter to $290M.

Based on HighVista Strategies's 13F filing for Q3 2024, filed 14 Nov 2024.